Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis Reply

被引：0
|
作者：
Toovey, Stephen [1 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
DRUG SAFETY | 2012年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1188 / 1190
页数：3
相关论文
共 50 条
  • [1] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
    Mark Jones
    Rokuro Hama
    Tom Jefferson
    Peter Doshi
    Drug Safety, 2012, 35 : 1187 - 1188
  • [2] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
    Jones, Mark
    Hama, Rokuro
    Jefferson, Tom
    Doshi, Peter
    DRUG SAFETY, 2012, 35 (12) : 1187 - 1188
  • [3] Short-term oseltamivir triggers neuropsychiatric adverse events
    Reactions Weekly, 2018, 1729 (1) : 11 - 11
  • [4] Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports
    Ueda, Natsumi
    Umetsu, Ryogo
    Abe, Junko
    Kato, Yamato
    Nakayama, Yoko
    Kato, Zenichiro
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (10) : 1638 - 1644
  • [5] Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment
    Smith, J. R.
    Sacks, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 596 - 605
  • [6] Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir A Comprehensive Review
    Toovey, Stephen
    Rayner, Craig
    Prinssen, Eric
    Chu, Tom
    Donner, Barbara
    Thakrar, Bharat
    Dutkowski, Regina
    Hoffmann, Gerhard
    Breidenbach, Alexander
    Lindemann, Lothar
    Carey, Ellen
    Boak, Lauren
    Gieschke, Ronald
    Sacks, Susan
    Solsky, Jonathan
    Small, Ian
    Reddy, David
    DRUG SAFETY, 2008, 31 (12) : 1097 - 1114
  • [7] Oseltamivir and Risk of Serious Neuropsychiatric Events
    Antoon, James W.
    Williams, Derek J.
    Bruce, Jean
    Sekmen, Mert
    Zhu, Yuwei
    Grijalva, Carlos G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 98 - 99
  • [8] Neuropsychiatric and Other Adverse Reactions to Oseltamivir (Tamiflu)
    Brown, J. A.
    Gunja, N.
    Graudins, A.
    CLINICAL TOXICOLOGY, 2010, 48 (03) : 257 - 257
  • [9] ADVERSE EFFECTS OF OSELTAMIVIR Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012
    Hoffman, Keith B.
    Demakas, Andrea
    Erdman, Colin B.
    Dimbil, Mo
    Doraiswamy, P. Murali
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [10] Post-Marketing Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: An Updated Review
    Stephen Toovey
    Eric P. Prinssen
    Craig R. Rayner
    Bharat T. Thakrar
    Regina Dutkowski
    Annette Koerner
    Tom Chu
    Alexandra Sirzen-Zelenskaya
    Markus Britschgi
    Sudhir Bansod
    Barbara Donner
    Advances in Therapy, 2012, 29 : 826 - 848
12345